Position in INCY
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$10,848,211
-$916,694 QoQ
Shares Held
95,697
-23.4% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#159
of 849 holders
Holding Since
Sep 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LBP AM SA holds $68,103,102 across 9 Biotechnology names. INCY ranks #2 (15.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BNTX |
BioNTech SE
|
388,498 | $36,149,738 | |
| 2 | INCY |
Incyte Corp
This page
|
95,697 | $10,848,211 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,597 | $7,747,497 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,206 | $4,276,432 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
93,906 | $3,663,273 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
17,947 | $2,057,982 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,005 | $1,873,737 | |
| 8 | RPRX |
Royalty Pharma plc
|
22,589 | $1,266,565 |
All Filings in INCY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,848,211 | 95,697 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $11,764,905 | 124,999 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $22,858,044 | 231,427 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $20,244,571 | 238,705 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $12,171,581 | 178,731 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $11,720,845 | 193,573 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $13,904,550 | 201,311 | Shares | Sole | 2025-02-10 | |
| 2023-12-31 | $440,283 | 7,012 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $405,083 | 7,012 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||